Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1993-10-21
|
pubmed:abstractText |
The prognostic significance of cathepsin-D expression was evaluated by immunohistochemistry in 638 node-positive breast carcinomas diagnosed between 1980 and 1986. A minimum of 2.5 years of follow-up was available for each patient (maximum: 9.5 years). Cathepsin-D expression was assessed separately both in cancer and in stromal cells using a commercially available polyclonal antibody. While cancer-cell immunostaining was not associated with prognosis, positive staining of stromal elements was related to shorter metastasis-free survival. The difference in distant metastasis-free survival between positive and negative expressors was greatest in the sub-group of patients submitted to adjuvant chemotherapy, with a hazard ratio for occurrence of distant metastasis of 1.76 by multivariate analysis, but was lowest for those receiving hormone therapy. Cathepsin-D expression by stromal cells was related to HER-2/neu oncoprotein expression, HSP-27 expression, poor nuclear grade, aneuploidy, and absence of estrogen and progesterone receptors. No association was found with the number of involved lymph nodes, tumor size, age, histologic grade, S-phase fraction, or vascular invasion. Our study suggests that cathepsin-D expression by stromal cells (and not by cancer cells) affects the prognosis of breast cancer, that stromal cells probably play a key role in local invasion and metastatic dissemination of the tumor, and that the prognostic significance of cathepsin-D expression may vary according to the type of adjuvant therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
429-35
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:8397164-Adult,
pubmed-meshheading:8397164-Aged,
pubmed-meshheading:8397164-Aged, 80 and over,
pubmed-meshheading:8397164-Breast Neoplasms,
pubmed-meshheading:8397164-Carcinoma,
pubmed-meshheading:8397164-Carcinoma, Intraductal, Noninfiltrating,
pubmed-meshheading:8397164-Cathepsin D,
pubmed-meshheading:8397164-Female,
pubmed-meshheading:8397164-Humans,
pubmed-meshheading:8397164-Lymphatic Metastasis,
pubmed-meshheading:8397164-Middle Aged,
pubmed-meshheading:8397164-Prognosis,
pubmed-meshheading:8397164-Survival Analysis
|
pubmed:year |
1993
|
pubmed:articleTitle |
Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: an immunohistochemical study.
|
pubmed:affiliation |
Department of Pathology, Université Laval, L'Hôtel-Dieu de Québec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|